Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Pharmaceutical Development - Late Phase
Enabling Confidence and Security in the Supply Chain
Specialising in solid oral dosage forms, Almac has the technical experience and knowledge to develop robust formulations and manufacturing processes.
We have assisted many of our clients in the development of both immediate and modified release formulations, for their late stage clinical trials, registration batch manufacturing and commercial launches. Our expertise covers the development of the following dosage forms:
- Immediate and modified release capsules
- Immediate and modified release tablets
- Fixed dose combinations
- Powder / granule filled sachets
When developing modified release dosage forms, we often employ one of the following approaches to achieve the desired release profile:
- Insoluble / swellable
- Eroding matrix
- Coated pellets
- Coated tablets
- pH Sensitive coatings
Our manufacturing technologies and processing scales range from hundreds of grams for small-scale process investigation studies to hundreds of kilograms for phase III/IV and registration batches.
We understand that the best way to ensure a smooth regulatory review process for an NDA or MAA is to clearly present the results from a well-defined series of experiments. By understanding the parameters that are critical to the quality of the product and the safety of the patient, we build quality into the product from the start, implementing effective control strategies.
News: Learn about out Pharmaceutical Development Expansion to Charnwood Campus here.